Word: squibbs
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...many sick women," Ralph Knowles, the plaintiffs' attorney in the class-action suit, announced today. "I didn't think it was going to be anything like that. If I did, we would never have agreed to the $4.25 billion." Discussions are underway to convince Dow Corning, Bristol-Myers Squibb and other implant makers to add billions more to what is already the largest product-liability settlement in U.S. history. A partial analysis of claims finds that more than 70,000 women likely would be eligible to get money in the first wave of payments. Women who expected payments...
Hydroxyurea, made by Bristol-Myers Squibb, is available for $100 a month, but insurers won't pay for it until the Food and Drug Administration specifically approves a sickle-cell...
...record settlement that must still be approved by a federal judge, Dow Corning, Bristol-Myers Squibb and Baxter Healthcare -- makers of silicone breast implants -- agreed to pay some $4 billion over 30 years to the thousands of women who claim that they were made sick by the implants...
That said, the results reported last week by New Jersey-based Bristol-Myers Squibb in the journal Science were unusually promising, and they may give new momentum to this line of research. The monoclonal antibodies used against cancer are proteins designed to latch on to a specific molecule on the surface of a tumor cell, while leaving normal cells untouched. In Bristol-Myers Squibb's experiment, the antibody was linked with the common anticancer drug doxorubicin, and unlike many previous preparations, this combination enabled the drug to enter tumor cells, killing them from the inside...
...even the scientists from Bristol-Myers Squibb admit that any euphoria is premature. "I was surprised by the amount of press attention our study received," said Pamela Trail, who led the research team. "Obviously, we're tremendously excited by our data, but the true proof will be in the human trials." Within the next six months, the company will seek the Food and Drug Administration's permission to begin those crucial tests -- and perhaps generate more meaningful headlines...